Cost and cost-effectiveness: consistent terminology is needed

Comment

J K Marshall et al. Am J Gastroenterol. 1999 Apr.

. 1999 Apr;94(4):1108-9.

doi: 10.1111/j.1572-0241.1999.01108.x.

No abstract available

Comment on

A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
Das A. Das A. Am J Gastroenterol. 1998 Oct;93(10):1895-900. doi: 10.1111/j.1572-0241.1998.00545.x. Am J Gastroenterol. 1998. PMID: 9772051

Assessing cost effectiveness of empirical and prophylactic therapy for managing leptospirosis outbreaks.
Galloway RL, Levett PN, Tumeh JW, Flowers CR. Galloway RL, et al. Epidemiol Infect. 2009 Sep;137(9):1323-32. doi: 10.1017/S0950268808001751. Epub 2009 Jan 23. Epidemiol Infect. 2009. PMID: 19161641
Is antibiotic prophylaxis for bacterial endocarditis cost-effective?
Agha Z, Lofgren RP, VanRuiswyk JV. Agha Z, et al. Med Decis Making. 2005 May-Jun;25(3):308-20. doi: 10.1177/0272989X05276852. Med Decis Making. 2005. PMID: 15951458
Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
Akker-van Marle ME, Rijnders ME, Dommelen P, Fekkes M, Wouwe JP, Amelink-Verburg MP, Verkerk PH. Akker-van Marle ME, et al. BJOG. 2005 Jun;112(6):820-6. doi: 10.1111/j.1471-0528.2005.00555.x. BJOG. 2005. PMID: 15924544
[Antibiotic prophylaxis of hematogenous bacterial arthritis].
Kaandorp CJ, van Schaardenburg D, Krijnen P. Kaandorp CJ, et al. Ned Tijdschr Geneeskd. 1999 Sep 4;143(36):1808-11. Ned Tijdschr Geneeskd. 1999. PMID: 10526583 Review. Dutch.
An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases.
Kymes SM. Kymes SM. Ophthalmic Epidemiol. 2008 Mar-Apr;15(2):76-83. doi: 10.1080/09286580801939346. Ophthalmic Epidemiol. 2008. PMID: 18432490 Review.